Description: Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Home Page: www.codiagnostics.com
CODX Technical Analysis
2401 South Foothill Drive
Salt Lake City,
UT
84109
United States
Phone:
801 438 1036
Officers
Name | Title |
---|---|
Mr. Dwight H. Egan | Chairman, CEO & Pres |
Mr. Brian L. Brown CPA | CFO & Company Sec. |
Mr. Reed L. Benson | Gen. Counsel |
Dr. Brent C. Satterfield Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Mr. Dan Bohrer CPA | VP of Fin. & Accounting |
Dr. Mark Poritz Ph.D. | Chief Scientific Officer |
Mr. Andrew Benson | Head of Investor Relations |
Dr. Mayuranki Almaula | Sr. VP of Overseas Operations & Strategic Alliances |
Mr. Cameron Gundry | Head of Commercialization LATAM/EUR |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 16 |
---|---|
Trailing PE: | 5.0385 |
Price-to-Book MRQ: | 0.6346 |
Price-to-Sales TTM: | 1.4524 |
IPO Date: | 2017-07-12 |
Fiscal Year End: | December |
Full Time Employees: | 101 |